Literature DB >> 23143406

Major histocompatibility complex class II deficiency in Kuwait: clinical manifestations, immunological findings and molecular profile.

Waleed Al-Herz1, Osama Alsmadi, Motasem Melhem, Mike Recher, Francesco Frugoni, Luigi D Notarangelo.   

Abstract

Major Histocompatibility Complex (MHC) class II deficiency is a combined primary immunodeficiency disease that leads to overwhelming and recurrent infections. It was found to account for 19 % of combined immune deficiency cases in the National Primary Immunodeficiency Disorders Registry in Kuwait, a country with high prevalence of consanguinity. We present the clinical, immunologic and molecular features of 11 Kuwaiti patients who presented with MHC class II deficiency between 2004 and 2011.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23143406     DOI: 10.1007/s10875-012-9831-8

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  13 in total

Review 1.  Genetic control of MHC class II expression.

Authors:  Jenny Pan-Yun Ting; John Trowsdale
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

Review 2.  Hematopoietic stem cell transplantation and other management strategies for MHC class II deficiency.

Authors:  Capucine Picard; Alain Fischer
Journal:  Immunol Allergy Clin North Am       Date:  2010-05       Impact factor: 3.479

3.  Clinical, immunologic and genetic profiles of DOCK8-deficient patients in Kuwait.

Authors:  Waleed Al-Herz; Raj Ragupathy; Michel J Massaad; Raja'a Al-Attiyah; Arti Nanda; Karin R Engelhardt; Bodo Grimbacher; Luigi Notarangelo; Talal Chatila; Raif S Geha
Journal:  Clin Immunol       Date:  2012-03-30       Impact factor: 3.969

4.  Clinical course of patients with major histocompatibility complex class II deficiency.

Authors:  M A Saleem; P D Arkwright; E G Davies; A J Cant; P A Veys
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

5.  Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients.

Authors:  Monia Ouederni; Quentin B Vincent; Pierre Frange; Fabien Touzot; Sami Scerra; Mohamed Bejaoui; Aziz Bousfiha; Yves Levy; Barbara Lisowska-Grospierre; Danielle Canioni; Julie Bruneau; Marianne Debré; Stéphane Blanche; Laurent Abel; Jean-Laurent Casanova; Alain Fischer; Capucine Picard
Journal:  Blood       Date:  2011-09-08       Impact factor: 22.113

6.  The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population.

Authors:  Hamid Naamane; Ouafaa El Maataoui; Fatima Ailal; Abdelhamid Barakat; Siham Bennani; Jilali Najib; Mohammed Hassar; Rachid Saile; Ahmed Aziz Bousfiha
Journal:  Eur J Pediatr       Date:  2010-04-23       Impact factor: 3.183

7.  Human leucocyte antigen-identical haematopoietic stem cell transplantation in major histocompatiblity complex class II immunodeficiency: reduced survival correlates with an increased incidence of acute graft-versus-host disease and pre-existing viral infections.

Authors:  Raffaele Renella; Capucine Picard; Bénédicte Neven; Marie Ouachée-Chardin; Jean-Laurent Casanova; Françoise Le Deist; Marina Cavazzana-Calvo; Stéphane Blanche; Alain Fischer
Journal:  Br J Haematol       Date:  2006-09       Impact factor: 6.998

8.  Parental consanguinity and the risk of primary immunodeficiency disorders: report from the Kuwait National Primary Immunodeficiency Disorders Registry.

Authors:  Waleed Al-Herz; Kamal K Naguib; Luigi D Notarangelo; Raif S Geha; Amal Alwadaani
Journal:  Int Arch Allergy Immunol       Date:  2010-07-27       Impact factor: 2.749

Review 9.  Cellular and gene therapy for major histocompatibility complex class II deficiency.

Authors:  Franck Matheux; Jean Villard
Journal:  News Physiol Sci       Date:  2004-06

10.  Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study.

Authors:  William T Shearer; Howard M Rosenblatt; Rebecca S Gelman; Rebecca Oyomopito; Susan Plaeger; E Richard Stiehm; Diane W Wara; Steven D Douglas; Katherine Luzuriaga; Elizabeth J McFarland; Ram Yogev; Mobeen H Rathore; Wende Levy; Bobbie L Graham; Stephen A Spector
Journal:  J Allergy Clin Immunol       Date:  2003-11       Impact factor: 10.793

View more
  7 in total

Review 1.  Human inborn errors of immunity to herpes viruses.

Authors:  Emmanuelle Jouanguy; Vivien Béziat; Trine H Mogensen; Jean-Laurent Casanova; Stuart G Tangye; Shen-Ying Zhang
Journal:  Curr Opin Immunol       Date:  2020-01-31       Impact factor: 7.486

2.  First report on the Moroccan registry of primary immunodeficiencies: 15 years of experience (1998-2012).

Authors:  A A Bousfiha; L Jeddane; N El Hafidi; N Benajiba; N Rada; J El Bakkouri; A Kili; S Benmiloud; I Benhsaien; I Faiz; O Maataoui; Z Aadam; A Aglaguel; L Ait Baba; Z Jouhadi; R Abilkassem; M Bouskraoui; M Hida; J Najib; H Salih Alj; F Ailal
Journal:  J Clin Immunol       Date:  2014-03-12       Impact factor: 8.317

3.  Inherited human c-Rel deficiency disrupts myeloid and lymphoid immunity to multiple infectious agents.

Authors:  Romain Lévy; David Langlais; Vivien Béziat; Franck Rapaport; Geetha Rao; Tomi Lazarov; Mathieu Bourgey; Yu J Zhou; Coralie Briand; Kunihiko Moriya; Fatima Ailal; Danielle T Avery; Janet Markle; Ai Ing Lim; Masato Ogishi; Rui Yang; Simon Pelham; Mehdi Emam; Mélanie Migaud; Caroline Deswarte; Tanwir Habib; Luis R Saraiva; Eman A Moussa; Andrea Guennoun; Bertrand Boisson; Serkan Belkaya; Ruben Martinez-Barricarte; Jérémie Rosain; Aziz Belkadi; Sylvain Breton; Kathryn Payne; Ibtihal Benhsaien; Alessandro Plebani; Vassilios Lougaris; James P Di Santo; Bénédicte Neven; Laurent Abel; Cindy S Ma; Ahmed Aziz Bousfiha; Nico Marr; Jacinta Bustamante; Kang Liu; Philippe Gros; Frédéric Geissmann; Stuart G Tangye; Jean-Laurent Casanova; Anne Puel
Journal:  J Clin Invest       Date:  2021-09-01       Impact factor: 19.456

4.  Clinical, immunological and genetic findings of a large tunisian series of major histocompatibility complex class II deficiency patients.

Authors:  Imen Ben-Mustapha; Khaoula Ben-Farhat; Naouel Guirat-Dhouib; Emna Dhemaied; Beya Larguèche; Meriem Ben-Ali; Jalel Chemli; Jihène Bouguila; Lamia Ben-Mansour; Fethi Mellouli; Monia Khemiri; Mohamed Béjaoui; Mohamed-Ridha Barbouche
Journal:  J Clin Immunol       Date:  2013-01-13       Impact factor: 8.317

Review 5.  Lessons from Genetic Studies of Primary Immunodeficiencies in a Highly Consanguineous Population.

Authors:  Mohamed-Ridha Barbouche; Najla Mekki; Meriem Ben-Ali; Imen Ben-Mustapha
Journal:  Front Immunol       Date:  2017-06-27       Impact factor: 7.561

Review 6.  Hematopoietic Cell Transplantation for MHC Class II Deficiency.

Authors:  Su Han Lum; Benedicte Neven; Mary A Slatter; Andrew R Gennery
Journal:  Front Pediatr       Date:  2019-12-11       Impact factor: 3.418

Review 7.  Getting in and Staying Alive: Role for Coronin 1 in the Survival of Pathogenic Mycobacteria and Naïve T Cells.

Authors:  Mayumi Mori; Jean Pieters
Journal:  Front Immunol       Date:  2018-07-10       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.